Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
CRBP
Shares outstanding
18,502,075 shares
Disclosed Ownership
980,610 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
12 Nov 2025, 16:24:37 UTC
Date of event
04 Nov 2025

Sponsored

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 5.3% ownership in Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CRBP) on 04 Nov 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CRBP).
  • Disclosed ownership: 5.3%.
  • Date of event: 04 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Nov 2025, 16:24.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.7% 873,313 0 873,313 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.7% 873,313 0 873,313 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.7% 873,313 0 873,313 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.6% 107,297 0 107,297 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0.6% 107,297 0 107,297 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0.6% 107,297 0 107,297 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 5.3% 980,610 0 980,610 /s/ Seth Levy Seth Levy, attorney-in-fact*